Sex Differences in GERD

Gastroesophageal reflux disease (GERD) is the most commonly diagnosed digestive disorder in the United States. Higher rates of non-erosive reflux disease (NERD) are found in females while higher rates of erosive reflux disease (ERD) are found in males. Pre-menopausal females appear to be protected from esophageal mucosal damage, as they demonstrate lower rates of ERD, Barrett’s esophagus, and esophageal adenocarcinoma. A protective effect of estrogen on the esophageal mucosa is thought to contribute to this decreased prevalence. A better understanding of sex-related differences in GERD may help alleviate the reported differences in outcomes between sexes regarding medical and surgical management.

[1]  Chuyen T. Nguyen,et al.  Overlap of Gastroesophageal Reflux Disease and Functional Dyspepsia and Yield of Esophagogastroduodenoscopy in Patients Clinically Fulfilling the Rome IV Criteria for Functional Dyspepsia , 2022, Frontiers in Medicine.

[2]  N. Shaheen,et al.  Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline , 2022, The American journal of gastroenterology.

[3]  J. Y. Lee,et al.  Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis , 2022, Journal of personalized medicine.

[4]  T. Charles,et al.  Effect of Hormonal Replacement Therapy on Gastroesophageal Reflux Disease and its Complications in Post-Menopausal Women. , 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  W. Lei,et al.  Heartburn Sensation in Non-Erosive Reflux Disease: Pattern of Superficial Sensory Nerves Expressing TRPV1 and Epithelial Cells Expressing ASIC3 Receptors. , 2021, American journal of physiology. Gastrointestinal and liver physiology.

[6]  D. Katzka,et al.  Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges. , 2021, Gastrointestinal endoscopy clinics of North America.

[7]  E. Savarino,et al.  ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro‐esophageal reflux disease , 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[8]  M. A. Khan,et al.  On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis , 2018, Gastroenterology research and practice.

[9]  H. El‐Serag,et al.  Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux , 2017, JAMA.

[10]  C. Gyawali,et al.  Management of Gastroesophageal Reflux Disease. , 2017, Gastroenterology.

[11]  R. Fass,et al.  Current Trends in the Management of Gastroesophageal Reflux Disease , 2017, Gut and liver.

[12]  Nayoung Kim,et al.  Sex and Gender Differences in Gastroesophageal Reflux Disease , 2016, Journal of neurogastroenterology and motility.

[13]  F. Mearin,et al.  Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease , 2016, BMC Gastroenterology.

[14]  T. Shimosegawa,et al.  Gender difference in gastro-esophageal reflux diseases. , 2016, World journal of gastroenterology.

[15]  C. Afaneh,et al.  Gastroesophageal reflux disease: A review of surgical decision making. , 2016, World journal of gastrointestinal surgery.

[16]  C. Ell,et al.  Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial , 2015, Current medical research and opinion.

[17]  Raul Badillo,et al.  Diagnosis and treatment of gastroesophageal reflux disease. , 2014, World journal of gastrointestinal pharmacology and therapeutics.

[18]  S. Menon,et al.  Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer? , 2014, United European gastroenterology journal.

[19]  N. Yamamichi,et al.  Background Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan , 2013, PloS one.

[20]  Christopher C Winchester,et al.  Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review , 2013, Gut.

[21]  K. Vega,et al.  Females without reflux symptoms or gastroesophageal reflux disease have less distal esophageal acid exposure than males without reflux symptoms or gastroesophageal reflux disease. , 2013, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[22]  M. Vela,et al.  Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease , 2013, The American Journal of Gastroenterology.

[23]  Bryan K. Smith,et al.  Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial , 2012, Obesity.

[24]  D. Sifrim,et al.  Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors , 2012, Gut.

[25]  S. Johansson,et al.  Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response , 2012, Scandinavian journal of gastroenterology.

[26]  P. Devitt,et al.  Effect of sex on symptoms associated with gastroesophageal reflux. , 2011, Archives of surgery.

[27]  M. Hongo,et al.  Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs—TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan , 2011, Journal of Gastroenterology.

[28]  H. El‐Serag,et al.  Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies , 2010, Alimentary pharmacology & therapeutics.

[29]  R. Fass,et al.  Nonerosive Reflux Disease (NERD) - An Update , 2010, Journal of neurogastroenterology and motility.

[30]  P. Devitt,et al.  Impact of Gender and Age on the Long-Term Outcome of Laparoscopic Fundoplication , 2009, World Journal of Surgery.

[31]  A. Leodolter,et al.  Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study , 2009, Alimentary pharmacology & therapeutics.

[32]  T. Shimosegawa,et al.  Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats , 2009, Scandinavian journal of gastroenterology.

[33]  G. Colditz,et al.  Postmenopausal hormone use and symptoms of gastroesophageal reflux. , 2008, Archives of internal medicine.

[34]  N. Pedersen,et al.  Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. , 2008, Gastroenterology.

[35]  C. Pellegrini,et al.  Long-Term Outcomes After Laparoscopic Antireflux Surgery , 2008, The American Journal of Gastroenterology.

[36]  H. S. Kim,et al.  The prevalence of and risk factors for erosive oesophagitis and non‐erosive reflux disease: a nationwide multicentre prospective study in Korea , 2007, Alimentary pharmacology & therapeutics.

[37]  J. Saltzman,et al.  Endoscopic treatment of gastroesophageal reflux disease: Effect of gender on clinical outcome , 2006, Scandinavian journal of gastroenterology.

[38]  H. Kagami,et al.  Effects of ovariectomy and estrogen replacement on rat oral mucosa. , 2005, Maturitas.

[39]  M. Davila,et al.  Features of Gastroesophageal Reflux Disease in Women , 2004, American Journal of Gastroenterology.

[40]  K. Hveem,et al.  Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. , 2003, JAMA.

[41]  P. Malfertheiner,et al.  Prevalence of extra‐oesophageal manifestations in gastro‐oesophageal reflux disease: an analysis based on the ProGERD Study , 2003, Alimentary pharmacology & therapeutics.

[42]  E. Verdu,et al.  Modulatory effects of estrogen in two murine models of experimental colitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[43]  F. Wunderlich,et al.  Estradiol Signaling via Sequestrable Surface Receptors. , 2001, Endocrinology.

[44]  I. Wiklund,et al.  Gastro‐oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole , 1998 .

[45]  P. Ask,et al.  Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease. , 1986, Scandinavian journal of gastroenterology.

[46]  E. Kovacs,et al.  Sex differences and estrogen modulation of the cellular immune response after injury. , 2008, Cellular immunology.